Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction.
Anastasia BeloglazkinaNikolai ZykAlexander MajougaElena K BeloglazkinaPublished in: Molecules (Basel, Switzerland) (2020)
This review presents the last decade of studies on the synthesis of various types of small-molecule inhibitors of the p53- Mouse double minute 2 homolog (MDM2) protein-protein interaction. The main focus is placed on synthetic approaches to such molecules, their cytotoxicity, and MDM2 binding characteristics.